Results 31 to 40 of about 5,774 (177)

Flanker Task Performance in Isolated Dystonia (Blepharospasm): A Focus on Sequential Effects

open access: yesBrain Sciences, 2020
Isolated dystonia manifests with involuntary muscle hyperactivity, but the extent of cognitive impairment remains controversial. We examined the executive functions in blepharospasm while accounting for motor symptom-related distractions as a factor ...
Max Pekrul   +4 more
doaj   +1 more source

Personality and psychopathological profile of patients and botulinum therapy for blepharospasm

open access: yesConsilium Medicum, 2023
Background. Blepharospasm (BS) includes non-motor symptoms manifested by psychopathological disorders. The impact of these disorders on patients' quality of life and therapy of motor symptoms with botulinum toxin is poorly understood. Aim.
Violetta A. Tolmacheva   +3 more
doaj   +1 more source

The Pain in Dystonia Scale (PIDS)—Validation in Craniofacial and Upper Limb Dystonia

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Pain is one of the most disabling non‐motor symptoms in adult‐onset isolated dystonia (AOID). The Pain in Dystonia Scale (PIDS) was developed and validated in cervical dystonia. Its applicability to other focal subtypes remains unknown.
Veronica Bruno   +24 more
wiley   +1 more source

Isolated focal dystonia phenotypes are associated with distinct patterns of altered microstructure

open access: yesNeuroImage: Clinical, 2018
Objective: Isolated adult-onset focal dystonia is considered a network disorder with disturbances to the motor basal ganglia and cerebellar circuits playing a pathophysiological role, but why specific body regions become affected remains unknown.
Brian D. Berman   +4 more
doaj   +1 more source

The Hidden Burden of Hemifacial Spasm: A Systematic Review of Non‐Motor Symptoms

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Hemifacial spasm (HFS) is a chronic neurological disorder characterized by involuntary contractions of facial muscles. Traditionally regarded as a motor condition, HFS encompasses a spectrum of non‐motor symptoms that are often overlooked but significantly affect patients’ quality of life.
Miriam Carvalho Soares   +2 more
wiley   +1 more source

Voxel-Mirrored Homotopic Connectivity of Resting-State Functional Magnetic Resonance Imaging in Blepharospasm

open access: yesFrontiers in Psychology, 2018
Objective: Several networks in human brain are involved in the development of blepharospasm. However, the underlying mechanisms for this disease are poorly understood. A voxel-mirrored homotopic connectivity (VMHC) method was used to quantify the changes
Jing Wei   +11 more
doaj   +1 more source

Impaired Topographic Organization in Patients With Idiopathic Blepharospasm

open access: yesFrontiers in Neurology, 2022
Background: Idiopathic blepharospasm (BSP) is a common adult-onset focal dystonia. Neuroimaging technology can be used to visualize functional and microstructural changes of the whole brain.Method: We used resting-state functional MRI (rs-fMRI) and graph
Yanbing Hou   +6 more
doaj   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz   +2 more
wiley   +1 more source

Orbicularis oculi myectomy as a treatment for blepharospasm in a case of Schwartz Jampel syndrome

open access: yesJournal of Ophthalmic & Vision Research, 2016
Purpose: To describe a patient with Schwartz Jampel vel Aberfeld syndrome (SJS) who underwent orbicularis oculi myectomy as a treatment for blepharospasm.
Bahram Eshraghi   +3 more
doaj   +1 more source

Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal

open access: yesToxins, 2021
For well over 30 years, the botulinum neurotoxin (BoNT) has been used for a large number of indications, some of which however have not been licensed. Admittedly, approval varies in many countries and this permits a large spectrum for evaluation.
Wolfgang H. Jost
doaj   +1 more source

Home - About - Disclaimer - Privacy